pou3f3b Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to POU3F3 Antibodies

POU3F3 antibodies are specialized immunological reagents designed to target the POU3F3 protein, a transcription factor critical for neuronal development and kidney function. These antibodies are classified into monoclonal (produced by a single B-cell clone) or polyclonal (derived from multiple clones), each offering distinct advantages in research and diagnostic applications . Their high specificity and binding affinity make them indispensable for techniques such as immunohistochemistry (IHC), Western blotting, and immunoprecipitation.

Structure and Characteristics

POU3F3 antibodies are typically raised in species like rabbit, goat, or sheep, providing flexibility in experimental design. Key attributes include:

  • Broad epitope recognition: Polyclonal antibodies recognize multiple binding sites on the POU3F3 protein, enhancing detection robustness .

  • Thermostability: These antibodies exhibit resistance to denaturation, making them suitable for harsh experimental conditions .

  • Cross-reactivity: Careful validation is required to ensure specificity, particularly when analyzing homologous proteins across species .

Immunohistochemistry

POU3F3 antibodies are widely used to study protein localization in tissues. For example, a study employing rabbit anti-POU3F3 antibodies demonstrated nuclear staining in renal tubules of wild-type mice, while mutant strains (L423P) exhibited altered kidney function .

Western Blotting

In cancer research, monoclonal POU3F3 antibodies (e.g., NBP1-83966) have been validated for detecting overexpressed POU3F3 in HEK293T lysates .

Functional Studies

In small-cell lung cancer (SCLC), POU3F3 antibodies revealed its role as a master regulator of tuft cell-like variants, with high expression correlating with dependency in specific SCLC subtypes .

Case Study: Pou3f3 Mutation in Mice

A seminal study analyzed mice harboring a L423P mutation in Pou3f3, leading to renal hypoplasia and electrolyte imbalances . Key findings:

ParameterWild-TypeHomozygous MutantP-Value
Plasma Urea (mmol/l)10.7 ± 0.920.8 ± 1.8<0.001
Creatinine (μmol/l)15.9 ± 1.016.5 ± 1.3<0.001
Potassium (mmol/l)4.6 ± 0.35.1 ± 0.4<0.001

Immunohistochemistry confirmed preserved nuclear localization of POU3F3 in mutant kidneys, suggesting functional impairment despite normal expression .

Challenges and Considerations

  • Cross-reactivity: Polyclonal antibodies may bind to homologous proteins in other species, necessitating species-specific validation .

  • Signal Optimization: POU3F3 antibodies require precise dilution (e.g., 1:200–1:500 for IHC) to avoid nonspecific binding .

  • Therapeutic Implications: While not yet therapeutic, POU3F3 antibodies serve as critical tools for studying kidney development and oncogenic pathways .

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
pou3f3b antibody; brn-1.0 antibody; pou1 antibody; pou23 antibody; zp23 antibody; zp23pou antibody; POU domain antibody; class 3 antibody; transcription factor 3-B antibody; Brain-specific homeobox/POU domain protein 1.0 antibody; Brain-1.0 antibody; zfBrn-1.0 antibody; POU domain protein 1 antibody; ZFPOU1 antibody; POU domain protein 23 antibody; ZP-23 antibody
Target Names
pou3f3b
Uniprot No.

Target Background

Function
Pou3f3b is a transcription factor that may play important roles in patterning the embryonic brain.
Database Links

KEGG: dre:30321

STRING: 7955.ENSDARP00000124688

UniGene: Dr.29717

Protein Families
POU transcription factor family, Class-3 subfamily
Subcellular Location
Nucleus.
Tissue Specificity
Predominantly expressed in the central nervous system.

Q&A

What is the POU3F3b antibody, and what are its primary applications in developmental biology research?

The POU3F3b antibody targets the POU domain class 3 homeobox 3 (POU3F3) transcription factor, critical for developmental processes including gill cover formation in zebrafish and neural patterning . Its applications include:

ApplicationKey Methodological NotesCited Protocols
Western BlotRequires 1–3 µg/mL antibody concentration; optimal for lysates from brain/spinal cord .Mouse spinal cord/brain .
ImmunocytochemistryUse 10 µg/mL for nuclear staining in fixed/permeabilized cells (e.g., Neuro-2a) .Neuro-2a cells, DAPI counter .
ImmunohistochemistryValidated for frozen sections; fixation with PFA/Triton X-100 recommended .Human SH-SY5Y cells .

Advanced Consideration: In zebrafish studies, POU3F3b-specific antibodies must distinguish between pou3f3a and pou3f3b paralogs, as both contribute to opercular development .

How do I choose between different POU3F3 antibodies for my research?

Selection depends on epitope specificity, host species, and validation in target tissues.

AntibodyEpitopeHostValidated SpeciesApplicationsCitations
NBP1-49872Internal regionGoatMouse, Human (predicted)Flow cytometry, ICC, IHC, WB
ABIN657418AA 294–323 (Central)RabbitHumanWB
NBP2-57011Recombinant proteinRabbitHuman, MouseICC/IF, IHC-Frozen , [PMID:33649223]

Methodological Tip: For cross-species studies, prioritize antibodies with validated reactivity (e.g., NBP1-49872 for mouse ) over predicted cross-reactivity (e.g., rat for NBP2-57011 ).

What strategies resolve conflicting data between POU3F3 antibody clones in the same experiment?

Conflicts often arise from epitope competition or nonspecific binding.

StrategyImplementationExample
Peptide BlockingPre-incubate antibody with immunogen peptide (e.g., HMLSHAHQWVTAL for NBP1-49872 ).Confirm epitope specificity.
Orthogonal ValidationUse qPCR or in situ hybridization to confirm POU3F3 mRNA expression.Correlate protein/mRNA localization .
Serial Antibody TestingTest multiple antibodies (e.g., NBP1-49872 vs. ABIN657418) on parallel samples.Identify clone-specific artifacts .

Case Study: In zebrafish gill cover studies, conflicting results between pou3f3a and pou3f3b antibodies may reflect paralog-specific roles .

How do cross-reactivity concerns affect interpretation in comparative species studies?

Cross-reactivity risks vary by host and epitope.

HostRisk FactorsMitigation
GoatHigher likelihood of nonspecific binding in human samples.Use rabbit antibodies (e.g., NBP2-57011 ).
RabbitPotential cross-reactivity with rodent proteins.Validate with species-specific controls .

Advanced Protocol: For human-mouse comparative studies, use NBP2-57011 (validated for both ) and include isotype controls (e.g., unimmunized rabbit IgG ).

What are best practices for optimizing POU3F3b antibody protocols in zebrafish embryos?

Zebrafish protocols require precise fixation and permeabilization.

StepOptimal ParametersRationale
Fixation4% PFA, 15–30 min at RT.Preserves protein structure .
Permeabilization0.15–0.5% Triton X-100 in PBS.Balances membrane integrity and antibody access .
Antibody Dilution10 µg/mL for ICC/IF; 1–3 µg/mL for WB.Minimizes background in dense tissues .
DetectionAlexa Fluor 488 secondary (2 µg/mL) for ICC .High signal-to-noise ratio.

Troubleshooting: Weak staining in embryos may indicate insufficient permeabilization; increase Triton X-100 concentration .

How to interpret nuclear vs. cytoplasmic POU3F3 staining in neural progenitor cells?

Nuclear localization confirms transcriptional activity, while cytoplasmic staining may indicate misfolding or post-translational modifications.

LocalizationBiological ImplicationExperimental Validation
NuclearActive transcriptional regulation (e.g., Brn-1/Oct-8 role).Confirm with DAPI colocalization .
CytoplasmicInactive pool or protein mislocalization.Compare to WT vs. mutant cell lines.

Advanced Analysis: Quantify nuclear-to-cytoplasmic ratios using ImageJ or CellProfiler to assess activation states.

What are the implications of POU3F3b antibody validation in human vs. zebrafish models?

SpeciesValidated AntibodiesKey ApplicationsLimitations
HumanNBP2-57011 , ABIN657418 Neural cell line studies (e.g., SH-SY5Y).Limited to predicted reactivity in zebrafish.
ZebrafishNBP1-49872 (predicted) Gill cover development .Requires orthogonal validation (e.g., CRISPR).

Methodological Note: For zebrafish studies, combine POU3F3b antibody staining with pou3f3b mRNA in situ hybridization to confirm specificity .

How to address batch-to-batch variability in POU3F3 antibody performance?

Variability arises from lot-specific epitope recognition.

StrategyImplementationOutcome
Lot TestingScreen multiple lots on control samples (e.g., Neuro-2a cells ).Identify optimal lot for consistent results.
TitrationPerform serial dilutions (0.25–2 µg/mL for ICC ) to determine working concentration.Normalize signal across experiments.
StorageAliquot and store at -20°C to prevent freeze-thaw cycles .Maintain antibody stability.

Case Study: In flow cytometry, batch differences in NBP1-49872 may require recalibration of compensation controls .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.